NCIt definition : Ependymal Tumors is an NCI Cancer Therapeutic Evaluation Program (CTEP) Simplified
Disease Classification (SDC) category used to organize cancer-related disease coding
that harmonizes with and supports reporting based on the global standard Medical Dictionary
for Drug Regulatory Reporting (MedDRA) terminology.;
https://campus.neurochirurgie.fr/article1744.html 2023 France audiovisual aids First Degree Family History Cancer Negative No History of Non-Cardiac Surgery KRAS Mutation Analysis Was Not Performed No Known History of Illicit Drug Use Family History of Stomach Cancer Absent No Response to Intervention for Kawasaki Disease Adjuvant Post-operative Chemotherapy Was Not Administered New Tumor Event After Initial Treatment Absent Adjuvant I-131 Therapy Negative Radiation History Negative NRAS Mutation Analysis Was Not Performed Therapeutic Ionizing Radiation to Head History Absent Has No Sibling NCI CTEP SDC Ependymal Tumors Sub-Category Terminology EGFR Mutation Analysis Was Not Performed Adjuvant Post-operative Immunological Therapy Was Not Administered No History of Rheumatic Fever Physician Diagnosed Diabetes Absent Preoperative IV Antiemetics were not Administered PDGFRA Mutation Analysis Was Not Performed Patient was Not Previously Evaluated for Current Chief Complaint No History of Neonatal Complication ROS1 Rearrangement Analysis Was Not Performed Targeted Molecular Therapy Was Not Administered as an Additional Treatment for a New
Tumor Event Intercurrent Illness is Absent at Onset of Chief Complaint TP53 Mutation Analysis Was Not Performed ATRX Mutation Analysis Was Not Performed 10q23/PTEN Locus Deletion Analysis Was Not Performed Chief Complaint Not Caused by Trauma Additional Surgery for New Metastatic Tumor Event Was Not Performed Evidence of Disease Absent after Completion of Therapy Other Preoperative IV Medications were not Administered Additional Surgery for New Tumor Event Absent Preoperative IV Antacids were not Administered ependymoma, nos Nitric Oxide New Disease is not Multifocal No History of Kawasaki Disease ERBB2 Mutation Analysis Was Not Performed Not Lost to Follow-Up Lymph Node Dissection Was Not Performed No History of Gestational Complication RET Rearrangement Analysis Was Not Performed KIT Mutation Analysis Was Not Performed Intervention Not Given for Kawasaki Disease First Degree Family History of Primary Brain Tumor Negative Adjuvant Post-operative Radiation Therapy Was Not Administered No History of Other Muscular Dystrophy or Glycogen Storage Disorder BRAF Mutation Analysis Was Not Performed History of Colorectal Cancer Negative Immunotherapy Was Not Administered as an Additional Treatment for a New Tumor Event Chemical/Occupational Exposure Absent Regional Anesthesia was not Administered Additional Molecular Studies Were Not Performed Chemotherapy Was Not Administered as an Additional Treatment for a New Tumor Event SDH Complex Mutation Analysis Was Not Performed Hormone Therapy Was Not Administered as an Additional Treatment for a New Tumor Event Regular Smokeless Tobacco Use for Six Weeks or More Negative MGMT Promoter Methylation Testing Was Not Performed NON Mouse Additional Surgery for New Loco-Regional Tumor Event Was Not Performed Medication Not Taken Neither Hypertension Absent Bone Marrow Aspirate Immunophenotyping and Cytochemistry Were Not Performed Preoperative IV Sedation was Not Administered Neither Case or Control Status Preoperative IV Opiates were not Administered Chief Complaint was Not Witnessed Chemotherapy Not Received Radiation Was Not Administered as an Additional Treatment for a New Tumor Event Radiation Therapy Not Received Paraneoplastic Syndrome is Not Present History of Medical Treatment Absent Peripheral Blood Immunophenotyping and Cytochemistry Were Not Performed Documentation Absent Caffeine Not Routinely Consumed Use of Smokeless Tobacco at Time of Diagnosis Negative Subsequent Known Primary Melanoma(s) Not Found During the Follow-Up Interferon Gamma Treatment was not Administered 90 Days Prior to Specimen Resection IDH Family Wildtype ependymoma IV Anesthesia was not Administered Interferon Gamma Treatment was not Administered Prior to Specimen Resection Negation 1p/19q Deletion Analysis Was Not Performed Adjuvant Post-operative Pharmaceutical Therapy Was Not Administered ATRX Gene Mutation Negative Another Form of Birth Control was not Used Norway Fluorescence In Situ Hybridization Was Not Performed EGFR Gene Amplification Negative ALK Rearrangement Analysis Was Not Performed Patient was not Postmenopausal with no Prior Oophorectomy No History of Myopathy No History of Congenital Heart Disease Minor Criteria for Rheumatic Heart Disease Not Present PTEN Mutation Analysis Was Not Performed Routine Cytogenetics Were not Completed First Degree Family History Thyroid Cancer Negative Cancer History Absent No Known History of Alcohol Use Multiple Known Primary Tumors Absent at Initial Melanoma Diagnosis Any Metastatic Diagnosis Absent Unemployed Tumor Reoccurrence Absent After Initial Treatment BRAF Rearrangement Analysis Was Not Performed Local Anesthesia Agents were not Administered NF1 Mutation Analysis Was Not Performed Tumor Progression Absent After Initial Treatment PTEN Gene Mutation Negative MET Mutation Analysis Was Not Performed Nitric Oxide Measurement EGFR Amplification Analysis Was Not Performed Additional Immunohistochemistry Was Not Performed IDH Family Mutation Analysis Was Not Performed Adjuvant Post-operative Targeted Molecular Therapy Was Not Administered
Automatic exact mappings (from CISMeF team)